Who are live attenuated Japanese encephalitis vaccine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): bOPV (two dose), Oral Polio Vaccine, Vivotif Typhoid Oral Vaccine, Rotavirus Vaccine, Live, Pentavalent, RotaTeq, Rotateq vaccine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/live-attenuated-japanese-encephalitis-vaccine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

live attenuated Japanese encephalitis vaccine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

live attenuated Japanese encephalitis vaccine (live attenuated Japanese encephalitis vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology.

marketed Live attenuated vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

live attenuated Japanese encephalitis vaccine (live attenuated Japanese encephalitis vaccine) — Chinese Academy of Medical Sciences. This live attenuated vaccine stimulates immune responses against Japanese encephalitis virus by introducing a weakened form of the virus that replicates but does not cause disease.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
live attenuated Japanese encephalitis vaccine TARGET	live attenuated Japanese encephalitis vaccine	Chinese Academy of Medical Sciences	marketed	Live attenuated vaccine
bOPV (two dose)	bOPV (two dose)	Centers for Disease Control and Prevention	marketed	Live attenuated vaccine	Poliovirus types 1 and 3
Oral Polio Vaccine	Oral Polio Vaccine	International Centre for Diarrhoeal Disease Research, Bangladesh	marketed	Live attenuated vaccine
Vivotif Typhoid Oral Vaccine	Vivotif Typhoid Oral Vaccine	University of Maryland, Baltimore	marketed	Live attenuated vaccine
Rotavirus Vaccine, Live, Pentavalent	Rotavirus Vaccine, Live, Pentavalent	Sanofi Pasteur, a Sanofi Company	marketed	Live attenuated vaccine
RotaTeq	RotaTeq	National Institute of Pediatrics, Mexico	marketed	Live attenuated vaccine	Rotavirus VP4 and VP7 surface proteins
Rotateq vaccine	Rotateq vaccine	University Hospital, Brest	marketed	Live attenuated vaccine	Rotavirus VP4 and VP7 surface proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). live attenuated Japanese encephalitis vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/live-attenuated-japanese-encephalitis-vaccine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab